Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice. (Q48475377)

11 February 2018

title

Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice. (English)

1 reference

11 February 2018

author name string

Gero P Hooff

1

1 reference

11 February 2018

W Gibson Wood

2

1 reference

11 February 2018

Ji-Hyun Kim

3

1 reference

11 February 2018

Urule Igbavboa

4

1 reference

11 February 2018

Wei-Yi Ong

5

1 reference

11 February 2018

Walter E Muller

6

1 reference

11 February 2018

Gunter P Eckert

7

1 reference

11 February 2018

publication date

13 June 2012

1 reference

11 February 2018

published in

Molecular Neurobiology

1 reference

11 February 2018

volume

46

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

179-185

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s12035-012-8285-6

exact match

0 references

cites work

Cholesterol and apolipoprotein E in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Purification of brain peroxisomes and localization of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Lipid changes in the aged brain: effect on synaptic function and neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Brain cholesterol in normal and pathological aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Is hypercholesterolemia a risk factor for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Statins: drugs for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Brain membrane cholesterol domains, aging and amyloid beta-peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Lipid membranes and beta-amyloid: a harmful connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Isoprenoids, small GTPases and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Changes in brain cholesterol metabolome after excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Isoprenoids and Alzheimer's disease: a complex relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

21 January 2018

Isoprenylated proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Isoprenoids in aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

The lipid compositions of different regions of rat brain during development and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Lipid compositions of different regions of the human brain during aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Accumulation of dolichol in older tissues satisfies the proposed criteria to be qualified a biomarker of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

A rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Changes in cholesterol biosynthetic and transport pathways after excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Regulation of fatty acid synthesis by farnesyl pyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8285-6

Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice.

21 January 2018

1 reference

12 December 2020

Brain Cholesterol, Statins and Alzheimer’s Disease

1 reference

12 December 2020

Accumulation of dolichols in brains of elderly.

1 reference

12 December 2020

Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells

1 reference

12 December 2020

Age-dependent changes in the levels of dolichol and dolichyl phosphates in human brain

1 reference

12 December 2020

Membrane properties of dolichol in different age groups of mice

1 reference

12 December 2020

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth

1 reference

12 December 2020

A simple method for the isolation and purification of total lipides from animal tissues

1 reference

12 December 2020

Brain-membrane cholesterol in Alzheimer's disease

1 reference

12 December 2020

Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells

1 reference

12 December 2020

Age-dependent modifications in the metabolism of mevalonate pathway lipids in rat brain

1 reference

12 December 2020

10.1007/S12035-012-8285-6

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

22692983

1 reference

11 February 2018